Cargando…
A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease
Potentially inappropriate prescribing (PIP), including potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs), is a major risk factor for adverse drug reactions (ADRs). Establishing a risk warning model for PIP to screen high-risk patients and implementing targeted i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402906/ https://www.ncbi.nlm.nih.gov/pubmed/36034817 http://dx.doi.org/10.3389/fphar.2022.804566 |
_version_ | 1784773248251068416 |
---|---|
author | Xingwei, Wu Huan, Chang Mengting, Li Lv, Qin Jiaying, Zhang Enwu, Long Jiuqun, Zhu Rongsheng, Tong |
author_facet | Xingwei, Wu Huan, Chang Mengting, Li Lv, Qin Jiaying, Zhang Enwu, Long Jiuqun, Zhu Rongsheng, Tong |
author_sort | Xingwei, Wu |
collection | PubMed |
description | Potentially inappropriate prescribing (PIP), including potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs), is a major risk factor for adverse drug reactions (ADRs). Establishing a risk warning model for PIP to screen high-risk patients and implementing targeted interventions would significantly reduce the occurrence of PIP and adverse drug events. Elderly patients with cardiovascular disease hospitalized at the Sichuan Provincial People’s Hospital were included in the study. Information about PIP, PIM, and PPO was obtained by reviewing patient prescriptions according to the STOPP/START criteria (2nd edition). Data were divided into a training set and test set at a ratio of 8:2. Five sampling methods, three feature screening methods, and eighteen machine learning algorithms were used to handle data and establish risk warning models. A 10-fold cross-validation method was employed for internal validation in the training set, and the bootstrap method was used for external validation in the test set. The performances were assessed by area under the receiver operating characteristic curve (AUC), and the risk warning platform was developed based on the best models. The contributions of features were interpreted using SHapley Additive ExPlanation (SHAP). A total of 404 patients were included in the study (318 [78.7%] with PIP; 112 [27.7%] with PIM; and 273 [67.6%] with PPO). After data sampling and feature selection, 15 datasets were obtained and 270 risk warning models were built based on them to predict PIP, PPO, and PIM, respectively. External validation showed that the AUCs of the best model for PIP, PPO, and PIM were 0.8341, 0.7007, and 0.7061, respectively. The results suggested that angina, number of medications, number of diseases, and age were the key factors in the PIP risk warning model. The risk warning platform was established to predict PIP, PIM, and PPO, which has acceptable accuracy, prediction performance, and potential clinical application perspective. |
format | Online Article Text |
id | pubmed-9402906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94029062022-08-26 A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease Xingwei, Wu Huan, Chang Mengting, Li Lv, Qin Jiaying, Zhang Enwu, Long Jiuqun, Zhu Rongsheng, Tong Front Pharmacol Pharmacology Potentially inappropriate prescribing (PIP), including potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs), is a major risk factor for adverse drug reactions (ADRs). Establishing a risk warning model for PIP to screen high-risk patients and implementing targeted interventions would significantly reduce the occurrence of PIP and adverse drug events. Elderly patients with cardiovascular disease hospitalized at the Sichuan Provincial People’s Hospital were included in the study. Information about PIP, PIM, and PPO was obtained by reviewing patient prescriptions according to the STOPP/START criteria (2nd edition). Data were divided into a training set and test set at a ratio of 8:2. Five sampling methods, three feature screening methods, and eighteen machine learning algorithms were used to handle data and establish risk warning models. A 10-fold cross-validation method was employed for internal validation in the training set, and the bootstrap method was used for external validation in the test set. The performances were assessed by area under the receiver operating characteristic curve (AUC), and the risk warning platform was developed based on the best models. The contributions of features were interpreted using SHapley Additive ExPlanation (SHAP). A total of 404 patients were included in the study (318 [78.7%] with PIP; 112 [27.7%] with PIM; and 273 [67.6%] with PPO). After data sampling and feature selection, 15 datasets were obtained and 270 risk warning models were built based on them to predict PIP, PPO, and PIM, respectively. External validation showed that the AUCs of the best model for PIP, PPO, and PIM were 0.8341, 0.7007, and 0.7061, respectively. The results suggested that angina, number of medications, number of diseases, and age were the key factors in the PIP risk warning model. The risk warning platform was established to predict PIP, PIM, and PPO, which has acceptable accuracy, prediction performance, and potential clinical application perspective. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9402906/ /pubmed/36034817 http://dx.doi.org/10.3389/fphar.2022.804566 Text en Copyright © 2022 Xingwei, Huan, Mengting, Lv, Jiaying, Enwu, Jiuqun and Rongsheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Xingwei, Wu Huan, Chang Mengting, Li Lv, Qin Jiaying, Zhang Enwu, Long Jiuqun, Zhu Rongsheng, Tong A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title | A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title_full | A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title_fullStr | A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title_full_unstemmed | A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title_short | A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
title_sort | machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402906/ https://www.ncbi.nlm.nih.gov/pubmed/36034817 http://dx.doi.org/10.3389/fphar.2022.804566 |
work_keys_str_mv | AT xingweiwu amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT huanchang amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT mengtingli amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT lvqin amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT jiayingzhang amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT enwulong amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT jiuqunzhu amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT rongshengtong amachinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT xingweiwu machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT huanchang machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT mengtingli machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT lvqin machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT jiayingzhang machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT enwulong machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT jiuqunzhu machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease AT rongshengtong machinelearningbasedriskwarningplatformforpotentiallyinappropriateprescriptionsforelderlypatientswithcardiovasculardisease |